APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchOrthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) include Merck, Roche, GSK, Bayer, Sunstar, Showa Yakuhin Kako, Septodont, PerioChip and JandJ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Company

Merck

Roche

GSK

Bayer

Sunstar

Showa Yakuhin Kako

Septodont

PerioChip

JandJ

DenMat

Colgate-Palmolive

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type

Injection Type

Oral Type

Others

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application

Hospital

Clinic

Others

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends Table 2. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Drivers Table 3. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Opportunities and Challenges Table 4. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Restraints Table 5. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Manufacturers Table 9. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers, Product Type & Application Table 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Type Table 17. Major Manufacturers of Oral Type Table 18. Major Manufacturers of Others Table 19. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 21. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2027-2032) & (k units) Table 22. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2021-2026) Table 23. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2027-2032) Table 24. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (k units) Table 26. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2027-2032) & (k units) Table 27. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026) Table 28. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Others Table 32. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 34. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2027-2032) & (k units) Table 35. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2021-2026) Table 36. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2027-2032) Table 37. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (k units) Table 39. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2027-2032) & (k units) Table 40. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2021-2026) Table 41. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2027-2032) Table 42. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2021-2026) & (k units) Table 44. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2021-2026) Table 45. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 49. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2027-2032) & (k units) Table 50. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 52. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2027-2032) & (k units) Table 59. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2021-2026) Table 63. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2027-2032) Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 68. Merck Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 73. Roche Recent Development Table 74. GSK Company Information Table 75. GSK Business Overview Table 76. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 78. GSK Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 83. Bayer Recent Development Table 84. Sunstar Company Information Table 85. Sunstar Business Overview Table 86. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 88. Sunstar Recent Development Table 89. Showa Yakuhin Kako Company Information Table 90. Showa Yakuhin Kako Business Overview Table 91. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 93. Showa Yakuhin Kako Recent Development Table 94. Septodont Company Information Table 95. Septodont Business Overview Table 96. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 98. Septodont Recent Development Table 99. PerioChip Company Information Table 100. PerioChip Business Overview Table 101. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 103. PerioChip Recent Development Table 104. JandJ Company Information Table 105. JandJ Business Overview Table 106. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 108. JandJ Recent Development Table 109. DenMat Company Information Table 110. DenMat Business Overview Table 111. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 113. DenMat Recent Development Table 114. Colgate-Palmolive Company Information Table 115. Colgate-Palmolive Business Overview Table 116. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 118. Colgate-Palmolive Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors List Table 122. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Image Figure 2. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2021-2032) & (k units) Figure 5. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Type Image Figure 9. Oral Type Image Figure 10. Others Image Figure 11. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2021-2032) Figure 14. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2021-2032) Figure 23. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2021-2032) Figure 26. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2032) Figure 28. U.S. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2032) Figure 33. Germany Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2032) Figure 40. China Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2032) Figure 48. Brazil Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032) & (US$ Million) Figure 59. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Oral Type
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Merck
  • Roche
  • GSK
  • Bayer
  • Sunstar
  • Showa Yakuhin Kako
  • Septodont
  • PerioChip
  • JandJ
  • DenMat
  • Colgate-Palmolive

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
  1. 2.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
  2. 2.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Drivers
  3. 2.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Opportunities and Challenges
  4. 2.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Restraints
3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Manufacturers
  1. 3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers, Product Type & Application
  7. 3.7 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Tier 1, Tier 2, and Tier 3
4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Type
  1. 4.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Type Introduction
  2. 4.1.1 Injection Type
  3. 4.1.2 Oral Type
  4. 4.1.3 Others
  5. 4.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
  6. 4.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2032)
  8. 4.2.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type
  10. 4.3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2032)
  12. 4.3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2032)
5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
  1. 5.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
  6. 5.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2032)
  8. 5.2.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application
  10. 5.3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2032)
  12. 5.3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2021-2032)
6 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
  1. 6.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2021-2032)
  3. 6.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2021-2026)
  4. 6.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region
  1. 7.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region
  2. 7.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2021-2026)
  4. 7.1.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2027-2032)
  5. 7.1.4 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032)
  8. 7.2.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032)
  11. 7.3.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Sunstar
  26. 8.5.1 Sunstar Company Information
  27. 8.5.2 Sunstar Business Overview
  28. 8.5.3 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  30. 8.5.5 Sunstar Recent Developments
  31. 8.6 Showa Yakuhin Kako
  32. 8.6.1 Showa Yakuhin Kako Company Information
  33. 8.6.2 Showa Yakuhin Kako Business Overview
  34. 8.6.3 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  36. 8.6.5 Showa Yakuhin Kako Recent Developments
  37. 8.7 Septodont
  38. 8.7.1 Septodont Company Information
  39. 8.7.2 Septodont Business Overview
  40. 8.7.3 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  42. 8.7.5 Septodont Recent Developments
  43. 8.8 PerioChip
  44. 8.8.1 PerioChip Company Information
  45. 8.8.2 PerioChip Business Overview
  46. 8.8.3 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  48. 8.8.5 PerioChip Recent Developments
  49. 8.9 JandJ
  50. 8.9.1 JandJ Company Information
  51. 8.9.2 JandJ Business Overview
  52. 8.9.3 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  54. 8.9.5 JandJ Recent Developments
  55. 8.10 DenMat
  56. 8.10.1 DenMat Company Information
  57. 8.10.2 DenMat Business Overview
  58. 8.10.3 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  60. 8.10.5 DenMat Recent Developments
  61. 8.11 Colgate-Palmolive
  62. 8.11.1 Colgate-Palmolive Company Information
  63. 8.11.2 Colgate-Palmolive Business Overview
  64. 8.11.3 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  66. 8.11.5 Colgate-Palmolive Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Value Chain Analysis
  2. 9.1.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Mode & Process
  6. 9.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors
  9. 9.2.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst